Compositions for enhancing transport and antisense efficacy of nucleic acid analog into cells

Details for Australian Patent Application No. 2004235396 (hide)

Owner AVI BioPharma, Inc.

Inventors Kroeker, Andrew D.; Moulton, Hong M.; Iversen, Patrick L.; Nelson, Michelle H.; Stein, David A.

Agent Davies Collison Cave

Pub. Number AU-B-2004235396

PCT Pub. Number WO2004/097017

Priority 60/466,703 29.04.03 US

Filing date 29 April 2004

Wipo publication date 11 November 2004

Acceptance publication date 25 November 2010

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 49/00 (2006.01) Preparations for testing

C12N 15/87 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Event Publications

10 November 2005 PCT application entered the National Phase

  PCT publication WO2004/097017 Priority application(s): WO2004/097017

25 November 2010 Application Accepted

  Published as AU-B-2004235396

24 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004235398-Gasket for pipe coupling and pipe coupling incorporating same

2004235395-Methods for prognosis and treatment of solid tumors